Dr. Brian Harvey is a former Vice President of U.S. Regulatory Strategy at Pfizer. He also worked at the USFDA as Director of the Division of Gastroenterology Products. Dr. Harvey led the regulatory review for NDA and BLA submissions of major breakthrough drugs, including Humira, Remicade and Lialda. Throughout his FDA career, Dr. Harvey remained a practicing clinician at the Anne Arundel Medical Center in Maryland. He graduated with honors from Middlebury College in Vermont and earned his Ph.D. and M.D. at the University of Connecticut.